vs
Side-by-side financial comparison of Fidelity National Financial, Inc. (FNF) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Fidelity National Financial, Inc. is the larger business by last-quarter revenue ($544.0M vs $339.0M, roughly 1.6× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs -21.5%, a 34.7% gap on every dollar of revenue. On growth, Fidelity National Financial, Inc. posted the faster year-over-year revenue change (10.3% vs -2.7%). Over the past eight quarters, Fidelity National Financial, Inc.'s revenue compounded faster (13.7% CAGR vs 0.4%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FNF vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $544.0M | $339.0M |
| Net Profit | $-117.0M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 82.9% | 19.9% |
| Net Margin | -21.5% | 13.2% |
| Revenue YoY | 10.3% | -2.7% |
| Net Profit YoY | -126.0% | 19.3% |
| EPS (diluted) | $-0.44 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $544.0M | $339.0M | ||
| Q3 25 | $553.0M | $327.3M | ||
| Q2 25 | $547.0M | $321.4M | ||
| Q1 25 | $455.0M | $330.6M | ||
| Q4 24 | $493.0M | $348.5M | ||
| Q3 24 | $506.0M | $345.5M | ||
| Q2 24 | $504.0M | $336.2M | ||
| Q1 24 | $421.0M | — |
| Q4 25 | $-117.0M | $44.7M | ||
| Q3 25 | $358.0M | $38.7M | ||
| Q2 25 | $278.0M | $34.0M | ||
| Q1 25 | $83.0M | $58.0M | ||
| Q4 24 | $450.0M | $37.5M | ||
| Q3 24 | $266.0M | $33.8M | ||
| Q2 24 | $306.0M | $38.4M | ||
| Q1 24 | $248.0M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 82.9% | 19.9% | ||
| Q3 25 | 81.9% | 17.9% | ||
| Q2 25 | 69.8% | 16.8% | ||
| Q1 25 | 24.4% | 21.6% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 61.9% | 15.0% | ||
| Q2 24 | 90.9% | 11.8% | ||
| Q1 24 | 78.6% | — |
| Q4 25 | -21.5% | 13.2% | ||
| Q3 25 | 64.7% | 11.8% | ||
| Q2 25 | 50.8% | 10.6% | ||
| Q1 25 | 18.2% | 17.5% | ||
| Q4 24 | 91.3% | 10.8% | ||
| Q3 24 | 52.6% | 9.8% | ||
| Q2 24 | 60.7% | 11.4% | ||
| Q1 24 | 58.9% | — |
| Q4 25 | $-0.44 | $0.95 | ||
| Q3 25 | $1.33 | $0.81 | ||
| Q2 25 | $1.02 | $0.70 | ||
| Q1 25 | $0.30 | $1.17 | ||
| Q4 24 | $1.65 | $0.74 | ||
| Q3 24 | $0.97 | $0.66 | ||
| Q2 24 | $1.12 | $0.74 | ||
| Q1 24 | $0.91 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6B | $363.4M |
| Total DebtLower is stronger | $4.4B | $1.2B |
| Stockholders' EquityBook value | $7.4B | $911.5M |
| Total Assets | $109.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.59× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.6B | $363.4M | ||
| Q3 25 | $3.5B | $296.4M | ||
| Q2 25 | $3.3B | $292.9M | ||
| Q1 25 | $4.5B | $306.8M | ||
| Q4 24 | $3.5B | $320.8M | ||
| Q3 24 | $5.0B | $299.3M | ||
| Q2 24 | $4.9B | $344.4M | ||
| Q1 24 | $3.5B | — |
| Q4 25 | $4.4B | $1.2B | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.4B | $1.2B | ||
| Q1 25 | $4.4B | $1.2B | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.2B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $7.4B | $911.5M | ||
| Q3 25 | $8.4B | $849.2M | ||
| Q2 25 | $7.9B | $882.3M | ||
| Q1 25 | $7.9B | $820.8M | ||
| Q4 24 | $7.8B | $906.9M | ||
| Q3 24 | $8.1B | $878.9M | ||
| Q2 24 | $7.3B | $905.4M | ||
| Q1 24 | $7.1B | — |
| Q4 25 | $109.0B | $2.5B | ||
| Q3 25 | $106.6B | $2.4B | ||
| Q2 25 | $102.3B | $2.5B | ||
| Q1 25 | $98.2B | $2.5B | ||
| Q4 24 | $95.4B | $2.5B | ||
| Q3 24 | $94.7B | $2.5B | ||
| Q2 24 | $88.8B | $2.5B | ||
| Q1 24 | $84.5B | — |
| Q4 25 | 0.59× | 1.34× | ||
| Q3 25 | 0.53× | 1.44× | ||
| Q2 25 | 0.56× | 1.39× | ||
| Q1 25 | 0.56× | 1.49× | ||
| Q4 24 | 0.56× | — | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | $93.6M | ||
| Q3 25 | $1.3B | $111.3M | ||
| Q2 25 | $1.9B | $17.4M | ||
| Q1 25 | $1.1B | $116.6M | ||
| Q4 24 | $1.5B | $43.8M | ||
| Q3 24 | $2.4B | $48.8M | ||
| Q2 24 | $1.4B | $-27.4M | ||
| Q1 24 | $1.6B | — |
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | 3.66× | 2.88× | ||
| Q2 25 | 6.82× | 0.51× | ||
| Q1 25 | 13.43× | 2.01× | ||
| Q4 24 | 3.32× | 1.17× | ||
| Q3 24 | 8.89× | 1.44× | ||
| Q2 24 | 4.45× | -0.71× | ||
| Q1 24 | 6.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FNF
| Escrow Fees | $241.0M | 44% |
| Other Title Related Fees And Income | $182.0M | 33% |
| Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees | $87.0M | 16% |
| Insurance Contracts Home Warranty | $31.0M | 6% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
